Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2017

Aug 02, 2018

BUY
$72.11 - $85.47 $721 - $854
10 New
10 $2,000
Q3 2016

Sep 25, 2018

SELL
N/A
-6 Closed
0 $0
Q2 2016

Oct 01, 2018

BUY
N/A
4 Added 200.0%
6 $4,000
Q3 2015

Oct 29, 2018

BUY
N/A
2
2 $1,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Kovack Advisors, Inc. Portfolio

Follow Kovack Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kovack Advisors, Inc. with notifications on news.